HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic value of a dot immunobinding assay for human pulmonary hydatidosis.

Abstract
The diagnosis of human hydatidosis is primarily made using radiological and serological methods. Radiological methods are generally of low specificity and serological methods lack sensitivity, especially for pulmonary disease. In this study the capabilities of a new rapid test, the hydatid antigen dot immunobinding assay (HADIA), which was developed for the diagnosis of pulmonary hydatidosis, were studied and compared with another immunodiagnostic method, indirect hemagglutination (IHA). The study subjects included 18 patients, 9 women, 9 men; range 7 to 63 years; mean 30 years, with surgically proven pulmonary hydatidosis, a control group comprised of 14 patients; viral respiratory infections (1), cirrhosis (2), connective tissue disease (2), taeniasis (3), and 6 healthy donors. We found that the HA-DIA test had a sensitivity of 67% and specificity of 100%, and that the IHA test had a sensitivity of 50% and specificity of 100%. We conclude that HA-DIA is a simple, rapid, low cost assay that does not require instrumentation and has a higher sensitivity than IHA for the diagnosis of pulmonary hydatidosis.
AuthorsAli I Olut, Sibel Erguven, Salih Emri, Haluk Ozunlu, Hadi Akay
JournalThe Korean journal of parasitology (Korean J Parasitol) Vol. 43 Issue 1 Pg. 15-8 (Mar 2005) ISSN: 0023-4001 [Print] Korea (South)
PMID15793354 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Antibodies, Helminth
Topics
  • Adolescent
  • Adult
  • Antibodies, Helminth (blood)
  • Child
  • Echinococcosis, Pulmonary (diagnosis)
  • False Negative Reactions
  • False Positive Reactions
  • Female
  • Humans
  • Immunoblotting (methods)
  • Male
  • Middle Aged
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: